Privia Health Q1 revenue rises 7.5% to $415.2 million; GAAP net income falls 59%
Privia Health reported first quarter 2024 revenue of $415.2 million, up 7.5% from a year earlier, and reiterated its full-year 2024 guidance. GAAP net income fell to $3.0 million from $7.3 million and operating income fell to $0.8 million from $6.7 million, while non-GAAP adjusted EBITDA rose 18.1% to $19.9 million. Stock-based compensation was $11.9 million, up from $5.4 million, and the company did not change its outlook.
Key points
- Total revenue was $415.2 million versus $386.3 million in Q1 2023, up 7.5%
- Operating income was $0.8 million versus $6.7 million; net income was $3.0 million versus $7.3 million
- Non-GAAP adjusted net income rose 16.6% to $22.5 million; adjusted EBITDA rose 18.1% to $19.9 million
- Full-year 2024 guidance was reiterated, including GAAP revenue of $1,600 million to $1,675 million and adjusted EBITDA of $85 million to $90 million
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:49 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 09, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.